{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:43:00Z","timestamp":1778841780849,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejmp.2023.103151","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:58:35Z","timestamp":1696640315000},"page":"103151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Stability of metabolic tumor volume may enable radiotherapy dose painting in anal cancer"],"prefix":"10.1016","volume":"114","author":[{"given":"Ana Mar\u00eda","family":"Acosta Roa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilde Eide","family":"Skingen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernt Louni","family":"Rekstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Undseth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Espen","family":"Rusten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eivor","family":"Hernes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne Gr\u00f8nlie","family":"Guren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirik","family":"Malinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmp.2023.103151_b0005","first-page":"e96","article-title":"Rising Incidence and Improved Survival of Anal Squamous Cell Carcinoma in Norway, 1987\u20132016","volume":"18","author":"Guren","year":"2019","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ejmp.2023.103151_b0010","first-page":"924","article-title":"International trends in anal cancer incidence rates","volume":"46","author":"Islami","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"9","key":"10.1016\/j.ejmp.2023.103151_b0015","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.annonc.2021.06.015","article-title":"Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2606","volume":"32","author":"Rao","year":"2021","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.ejmp.2023.103151_b0020","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/0284186X.2021.1918763","article-title":"Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer","volume":"60","author":"Sl\u00f8rdahl","year":"2021","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.ejmp.2023.103151_b0025","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-020-01567-7","article-title":"Patterns of recurrence in anal cancer: a detailed analysis","volume":"15","author":"Nilsson","year":"2020","journal-title":"Radiat Oncol"},{"issue":"22","key":"10.1016\/j.ejmp.2023.103151_b0030","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/cncr.28860","article-title":"PET\/CT imaging in cancer: Current applications and future directions","volume":"120","author":"Farwell","year":"2014","journal-title":"Cancer"},{"issue":"1097","key":"10.1016\/j.ejmp.2023.103151_b0035","doi-asserted-by":"crossref","first-page":"20181006","DOI":"10.1259\/bjr.20181006","article-title":"Anal cancer chemoradiotherapy outcome prediction using 18F-fluorodeoxyglucose positron emission tomography and clinicopathological factors","volume":"92","author":"Rusten","year":"2019","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.ejmp.2023.103151_b0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12149-019-01416-y","article-title":"The prognostic role of FDG PET\/CT before combined radio-chemotherapy in anal cancer patients","volume":"34","author":"Leccisotti","year":"2020","journal-title":"Ann Nucl Med"},{"issue":"6","key":"10.1016\/j.ejmp.2023.103151_b0045","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3390\/cancers12061512","article-title":"Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer","volume":"12","author":"Le Thiec","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmp.2023.103151_b0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2019.03.014","article-title":"Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma","volume":"136","author":"Duimering","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2023.103151_b0055","unstructured":"Helsedirektoratet. Analkreft - Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppf\u00f8lging av analkreft (analcancer): Helsedirektoratet - Avdeling spesialisthelsetjenester; 2021."},{"key":"10.1016\/j.ejmp.2023.103151_b0060","series-title":"TNM Classification of Malignant Tumours","author":"Sobin","year":"2011"},{"issue":"5","key":"10.1016\/j.ejmp.2023.103151_b0065","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","article-title":"Australasian Gastrointestinal Trials Group (AGITG) Contouring Atlas and Planning Guidelines for Intensity-Modulated Radiotherapy in Anal Cancer","volume":"83","author":"Ng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.ejmp.2023.103151_b0070","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.21037\/qims-20-769","article-title":"Intrapatient repeatability of background 18F-FDG uptake on PET\/CT","volume":"11","author":"Wang","year":"2021","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"10.1016\/j.ejmp.2023.103151_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000348387","article-title":"Dosimetric parameters predictive of acute gastrointestinal toxicity in patients with anal carcinoma treated with concurrent chemotherapy and intensity-modulated radiation therapy","volume":"85","author":"DeFoe","year":"2013","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.ejmp.2023.103151_b0080","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic Normal Tissue Contouring Guidelines for Radiation Therapy: A Radiation Therapy Oncology Group Consensus Panel Atlas","volume":"83","author":"Gay","year":"2012","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"10","key":"10.1016\/j.ejmp.2023.103151_b0085","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-018-1197-1","article-title":"Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy","volume":"35","author":"Klausner","year":"2018","journal-title":"Med Oncol"},{"issue":"18","key":"10.1016\/j.ejmp.2023.103151_b0090","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.ejca.2015.08.029","article-title":"Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer","volume":"51","author":"Leon","year":"2015","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejmp.2023.103151_b0095","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/j.ijrobp.2011.12.062","article-title":"Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort","volume":"83","author":"Bentzen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejmp.2023.103151_b0100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ijrobp.2011.07.007","article-title":"Twenty-five-year experience with radical chemoradiation for anal cancer","volume":"83","author":"Tomaszewski","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejmp.2023.103151_b0105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2015.07.014","article-title":"A tumor control probability model for anal squamous cell carcinoma","volume":"116","author":"Muirhead","year":"2015","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ejmp.2023.103151_b0110","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ijrobp.2006.01.009","article-title":"FDG-PET\/CT in the evaluation of anal carcinoma","volume":"65","author":"Cotter","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejmp.2023.103151_b0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clon.2018.11.034","article-title":"Is There a Role for an 18F-fluorodeoxyglucose-derived Biological Boost in Squamous Cell Anal Cancer?","volume":"31","author":"Sabbagh","year":"2019","journal-title":"Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejmp.2023.103151_b0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.radonc.2016.08.011","article-title":"Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT)","volume":"121","author":"Durrant","year":"2016","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ejmp.2023.103151_b0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2011.06.003","article-title":"Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: A prospective validation","volume":"75","author":"Aerts","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejmp.2023.103151_b0130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1748-717X-9-146","article-title":"Challenges in using 18 F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer","volume":"9","author":"Wilson","year":"2014","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ejmp.2023.103151_b0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.radonc.2003.05.001","article-title":"A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy","volume":"69","author":"Roeske","year":"2003","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ejmp.2023.103151_b0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijrobp.2008.10.086","article-title":"Dose-Volume Relationships for Acute Bowel Toxicity in Patients Treated With Pelvic Nodal Irradiation for Prostate Cancer","volume":"75","author":"Fiorino","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179723001783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179723001783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:57:53Z","timestamp":1761105473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179723001783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":28,"alternative-id":["S1120179723001783"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2023.103151","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stability of metabolic tumor volume may enable radiotherapy dose painting in anal cancer","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2023.103151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103151"}}